Inmed announces us$4.5 million private placement

Vancouver, bc, feb. 5, 2021 /prnewswire/ - inmed pharmaceuticals inc. ("inmed" or the "company") (nasdaq:inm) (tsx:in), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol...

INM Ratings Summary

INM Quant Ranking